Several studies have demonstrated that EGFR kinase domain duplication typically results from an in-frame tandem duplication of exons 18–25, leading to constitutive activation of EGFR signaling via the formation of an intramolecular dimer in non-small cell lung cancer (NSCLC). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.